North China Pharmaceutical Co Ltd (600812) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.026x

Based on the latest financial reports, North China Pharmaceutical Co Ltd (600812) has a cash flow conversion efficiency ratio of 0.026x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥170.24 Million ≈ $24.91 Million USD) by net assets (CN¥6.67 Billion ≈ $976.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 600812 market cap for the company's overall valuation and market capitalisation.

North China Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how North China Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

North China Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of North China Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore North China Pharmaceutical Co Ltd (600812) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
The South Indian Bank Limited NSE:SOUTHBANK	-0.457x
Bakrie & Brothers Tbk JK:BNBR	-0.011x
Perrigo Company plc F:PIG	0.060x
Xpel Inc NASDAQ:XPEL	0.121x
NAPCO Security Technologies Inc NASDAQ:NSSC	0.072x
Two Harbors Investments Corp NYSE:TWO	0.033x
Sonic Automotive Inc NYSE:SAH	0.036x
UTI Asset Management Company Limited NSE:UTIAMC	0.005x

Annual Cash Flow Conversion Efficiency for North China Pharmaceutical Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of North China Pharmaceutical Co Ltd from 1998 to 2025. View 600812 live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥6.88 Billion ≈ $1.01 Billion	CN¥1.18 Billion ≈ $172.16 Million	0.171x	-7.24%
2024-12-31	CN¥6.67 Billion ≈ $976.71 Million	CN¥1.23 Billion ≈ $179.92 Million	0.184x	+12.77%
2023-12-31	CN¥6.27 Billion ≈ $917.56 Million	CN¥1.02 Billion ≈ $149.88 Million	0.163x	+1.30%
2022-12-31	CN¥6.23 Billion ≈ $911.41 Million	CN¥1.00 Billion ≈ $146.97 Million	0.161x	+7.75%
2021-12-31	CN¥7.02 Billion ≈ $1.03 Billion	CN¥1.05 Billion ≈ $153.68 Million	0.150x	+40.40%
2020-12-31	CN¥7.06 Billion ≈ $1.03 Billion	CN¥752.15 Million ≈ $110.06 Million	0.107x	-18.20%
2019-12-31	CN¥5.62 Billion ≈ $822.98 Million	CN¥732.97 Million ≈ $107.26 Million	0.130x	-7.23%
2018-12-31	CN¥5.51 Billion ≈ $806.58 Million	CN¥774.33 Million ≈ $113.31 Million	0.140x	+158.25%
2017-12-31	CN¥5.28 Billion ≈ $772.71 Million	CN¥287.25 Million ≈ $42.03 Million	0.054x	+164.46%
2016-12-31	CN¥5.29 Billion ≈ $774.28 Million	CN¥-446.53 Million ≈ $-65.34 Million	-0.084x	-463.04%
2015-12-31	CN¥5.27 Billion ≈ $771.13 Million	CN¥122.50 Million ≈ $17.92 Million	0.023x	+34.66%
2014-12-31	CN¥5.25 Billion ≈ $767.70 Million	CN¥90.56 Million ≈ $13.25 Million	0.017x	+153.00%
2013-12-31	CN¥4.15 Billion ≈ $606.67 Million	CN¥-135.03 Million ≈ $-19.76 Million	-0.033x	-112.90%
2012-12-31	CN¥4.18 Billion ≈ $611.39 Million	CN¥-63.92 Million ≈ $-9.35 Million	-0.015x	-108.83%
2011-12-31	CN¥1.31 Billion ≈ $192.27 Million	CN¥227.60 Million ≈ $33.30 Million	0.173x	+134.21%
2010-12-31	CN¥1.18 Billion ≈ $172.92 Million	CN¥-598.35 Million ≈ $-87.56 Million	-0.506x	-144.62%
2009-12-31	CN¥890.92 Million ≈ $130.37 Million	CN¥1.01 Billion ≈ $147.96 Million	1.135x	+74.64%
2008-12-31	CN¥1.67 Billion ≈ $244.43 Million	CN¥1.09 Billion ≈ $158.85 Million	0.650x	+42.40%
2007-12-31	CN¥1.46 Billion ≈ $213.02 Million	CN¥664.37 Million ≈ $97.22 Million	0.456x	+6.25%
2006-12-31	CN¥1.39 Billion ≈ $203.42 Million	CN¥597.12 Million ≈ $87.38 Million	0.430x	+179.39%
2005-12-31	CN¥1.46 Billion ≈ $213.37 Million	CN¥224.17 Million ≈ $32.80 Million	0.154x	-14.81%
2004-12-31	CN¥1.72 Billion ≈ $251.66 Million	CN¥310.39 Million ≈ $45.42 Million	0.180x	-14.31%
2003-12-31	CN¥2.76 Billion ≈ $403.19 Million	CN¥580.32 Million ≈ $84.92 Million	0.211x	-23.91%
2002-12-31	CN¥2.67 Billion ≈ $390.38 Million	CN¥738.50 Million ≈ $108.07 Million	0.277x	+103.57%
2001-12-31	CN¥2.70 Billion ≈ $395.23 Million	CN¥367.28 Million ≈ $53.74 Million	0.136x	+175.41%
2000-12-31	CN¥2.70 Billion ≈ $395.61 Million	CN¥133.49 Million ≈ $19.53 Million	0.049x	+135.17%
1999-12-31	CN¥2.66 Billion ≈ $389.44 Million	CN¥-373.62 Million ≈ $-54.67 Million	-0.140x	+17.86%
1998-12-31	CN¥1.91 Billion ≈ $279.75 Million	CN¥-326.74 Million ≈ $-47.81 Million	-0.171x	--

About North China Pharmaceutical Co Ltd

SHG:600812 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.28 Billion

CN¥8.75 Billion CNY

Market Cap Rank

#7921 Global

#1816 in China

Share Price

CN¥5.10

Change (1 day)

+0.39%

52-Week Range

CN¥4.20 - CN¥6.26

All Time High

CN¥18.60